Low rates of naturally occurring resistant variants to the NS5A inhibitor daclatasvir in HCV-1 null responders.
First Division of Gastroenterology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Università degli Studi di Milano, Milano, Italy. .Hepatology (Impact Factor: 12). 06/2012; DOI:10.1002/hep.25924
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.